Entry |
|
Symbol |
IKBKB
|
Name |
(RefSeq) inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
|
KO |
K07209 | inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] |
|
Organism |
cjc Callithrix jacchus (white-tufted-ear marmoset)
|
Pathway |
cjc04620 | Toll-like receptor signaling pathway |
cjc04621 | NOD-like receptor signaling pathway |
cjc04622 | RIG-I-like receptor signaling pathway |
cjc04625 | C-type lectin receptor signaling pathway |
cjc04658 | Th1 and Th2 cell differentiation |
cjc04660 | T cell receptor signaling pathway |
cjc04662 | B cell receptor signaling pathway |
cjc04920 | Adipocytokine signaling pathway |
cjc04932 | Non-alcoholic fatty liver disease |
cjc05163 | Human cytomegalovirus infection |
cjc05166 | Human T-cell leukemia virus 1 infection |
cjc05167 | Kaposi sarcoma-associated herpesvirus infection |
cjc05168 | Herpes simplex virus 1 infection |
cjc05170 | Human immunodeficiency virus 1 infection |
cjc05208 | Chemical carcinogenesis - reactive oxygen species |
cjc05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
cjc05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:cjc00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100393096 (IKBKB)
04014 Ras signaling pathway
100393096 (IKBKB)
04064 NF-kappa B signaling pathway
100393096 (IKBKB)
04668 TNF signaling pathway
100393096 (IKBKB)
04068 FoxO signaling pathway
100393096 (IKBKB)
04151 PI3K-Akt signaling pathway
100393096 (IKBKB)
04150 mTOR signaling pathway
100393096 (IKBKB)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
100393096 (IKBKB)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
100393096 (IKBKB)
04621 NOD-like receptor signaling pathway
100393096 (IKBKB)
04622 RIG-I-like receptor signaling pathway
100393096 (IKBKB)
04623 Cytosolic DNA-sensing pathway
100393096 (IKBKB)
04625 C-type lectin receptor signaling pathway
100393096 (IKBKB)
04660 T cell receptor signaling pathway
100393096 (IKBKB)
04658 Th1 and Th2 cell differentiation
100393096 (IKBKB)
04659 Th17 cell differentiation
100393096 (IKBKB)
04657 IL-17 signaling pathway
100393096 (IKBKB)
04662 B cell receptor signaling pathway
100393096 (IKBKB)
04062 Chemokine signaling pathway
100393096 (IKBKB)
09152 Endocrine system
04910 Insulin signaling pathway
100393096 (IKBKB)
04920 Adipocytokine signaling pathway
100393096 (IKBKB)
09156 Nervous system
04722 Neurotrophin signaling pathway
100393096 (IKBKB)
09158 Development and regeneration
04380 Osteoclast differentiation
100393096 (IKBKB)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100393096 (IKBKB)
05206 MicroRNAs in cancer
100393096 (IKBKB)
05208 Chemical carcinogenesis - reactive oxygen species
100393096 (IKBKB)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100393096 (IKBKB)
09162 Cancer: specific types
05212 Pancreatic cancer
100393096 (IKBKB)
05221 Acute myeloid leukemia
100393096 (IKBKB)
05220 Chronic myeloid leukemia
100393096 (IKBKB)
05215 Prostate cancer
100393096 (IKBKB)
05222 Small cell lung cancer
100393096 (IKBKB)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100393096 (IKBKB)
05170 Human immunodeficiency virus 1 infection
100393096 (IKBKB)
05161 Hepatitis B
100393096 (IKBKB)
05160 Hepatitis C
100393096 (IKBKB)
05171 Coronavirus disease - COVID-19
100393096 (IKBKB)
05164 Influenza A
100393096 (IKBKB)
05162 Measles
100393096 (IKBKB)
05168 Herpes simplex virus 1 infection
100393096 (IKBKB)
05163 Human cytomegalovirus infection
100393096 (IKBKB)
05167 Kaposi sarcoma-associated herpesvirus infection
100393096 (IKBKB)
05169 Epstein-Barr virus infection
100393096 (IKBKB)
05165 Human papillomavirus infection
100393096 (IKBKB)
09171 Infectious disease: bacterial
05132 Salmonella infection
100393096 (IKBKB)
05135 Yersinia infection
100393096 (IKBKB)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
100393096 (IKBKB)
05142 Chagas disease
100393096 (IKBKB)
09164 Neurodegenerative disease
05010 Alzheimer disease
100393096 (IKBKB)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100393096 (IKBKB)
05418 Fluid shear stress and atherosclerosis
100393096 (IKBKB)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100393096 (IKBKB)
04936 Alcoholic liver disease
100393096 (IKBKB)
04932 Non-alcoholic fatty liver disease
100393096 (IKBKB)
04931 Insulin resistance
100393096 (IKBKB)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
100393096 (IKBKB)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:cjc01001]
100393096 (IKBKB)
Enzymes [BR:cjc01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.10 IkappaB kinase
100393096 (IKBKB)
Protein kinases [BR:cjc01001]
Serine/threonine kinases: Other
IKK family [OT]
100393096 (IKBKB)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
13:complement(40944337..41003863)
|
AA seq |
756 aa
MSWSPSLTTQTCGTWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRDRWCL
EIQIMRRLSHPNVVAAREVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREG
AILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQSSLCT
SFVGTLQYLAPELLEQLKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSE
MDIVVSEDLNGTVKFSSSLPYPNNLNSVLAKRLEKWLQLMLMWHPRQRGTDPTYGPNGCF
KALDDILNSKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLA
LIPDKPATQCISDSKLNEGRTLDMDLVFLFDNSKVTYETQISPRPQPESVSYILQEPKRN
LAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLK
AKLDFFKTSIQIDLEKYNEQTEFGITSDKLLLAWREMEQAVERCGRENEVKLLVERMMAL
QTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQS
FEKKVRVIYTQLSKTVVCKQKALELLPKVEEVMSLMNEDEKTVVRLQEKRQKELWNLLKI
ACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTTSDSLPETAKKSEELVAEAQNLCILLE
NAIQDTVREQDQSFMALDWSWLQTEEEEHSCLEQAS |
NT seq |
2271 nt +upstreamnt +downstreamnt
atgagctggtcaccttccctgacaacccagacgtgtgggacctgggaaatgaaagagcgc
cttgggacagggggatttggaaatgtcatccgatggcacaatcaggaaacaggtgagcag
atcgccatcaagcagtgccggcaggagctcagcccacggaaccgagaccggtggtgcctg
gagatccagatcatgagaaggctgagccaccccaatgtggtggctgctcgggaggtccct
gaggggatgcagaacttggcgcccaatgacctacccctgctggccatggagtactgccaa
ggaggagatctccggaagtacctgaaccagtttgagaactgctgtggcctgcgggaagga
gccatcctcaccttgctgagtgacattgcctctgcacttaggtaccttcatgaaaacaga
atcatccatcgggatctaaagccagaaaacatcgtcctgcagcaaggagaacagaggtta
atacacaaaattattgacctaggatatgccaaagagctggatcagagcagtctttgcacg
tcgtttgtggggaccctgcagtacctggccccagagctgctggagcagctgaagtacacg
gtgactgtcgactactggagcttcggcaccctggctttcgagtgcatcacgggcttccgg
cccttcctccccaactggcagcccgtgcagtggcattcgaaagtccggcagaagagtgag
atggacattgttgtcagtgaagacttgaatggaacagtgaagttttcaagttctttacct
taccccaataatcttaacagtgtcctggctaagcgactggagaagtggctgcagctgatg
ctgatgtggcacccccggcagaggggcacggatcccacgtatgggcccaatggctgtttc
aaggccctggatgacatcttaaactcaaagctggttcatatcttgaacatggtcacaggc
accatccacacctatcctgtgacagaggacgagagtctgcagagcttgaaggccagaatc
cagcaggacacaggcatcccagaggaggaccaggagctgctgcaggaagcgggcctggca
ttgatccctgacaagcctgccactcagtgtatttcagacagcaagttaaatgagggccgc
acattggacatggatcttgtttttctcttcgacaacagtaaagtcacctatgagactcag
atctccccacggccccaacctgaaagtgtcagctatatccttcaagagcccaagaggaac
cttgccttctttcagctgaggaaggtgtggggccaggtctggcacagcatccagaccctg
aaggaggattgcaaccggctgcagcagggacagcgagctgccatgatgaatctcctccgg
aacaacagctgtctctccaagatgaagaattccatggcttccatgtctcagcagctcaag
gccaagttggatttcttcaaaaccagcatccagattgacctggagaagtacaacgagcaa
accgagtttggcatcacatcagataaactgctgctggcttggagggaaatggagcaggct
gtggagcgctgtgggcgggagaatgaagtgaaactcctggtggagcggatgatggcgctg
cagaccgacattgtggacttgcagaggagccccatgggccggaagcagggggggacactg
gatgacctagaggagcaagcaagggagctctacaggagactaagagaaaagccacgagac
cagcgaactgagggtgacagtcaggaaatggtgcggctgctgcttcaggcaattcagagc
tttgagaagaaagtgcgagtgatctatacacagctcagtaaaactgtggtttgcaagcag
aaggcactggaactgctgcccaaggtggaagaggtgatgagcttgatgaatgaggatgag
aagactgttgtccggctgcaggagaagcggcagaaggagctctggaatctcctgaagatc
gcttgtagcaaggtccgtggtcccgtcagtggaagccctgatagcatgaatgcctctcga
cttagccagcctgggcagctgatgtctcagccttccacgacctctgacagcttacccgag
acagccaagaagagtgaagaactggtggctgaagcacagaacctctgcatcctgctagaa
aatgccatacaggacaccgtgagggagcaagaccagagttttatggccctagactggagc
tggttacaaacagaagaagaagagcacagctgcctggagcaggcctcgtga |